| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Earned premiums | $3.91B+46.4% | $2.67B+48.4% | $1.80B+25.8% | $1.43B+22.7% | $1.17B+22.2% | $955.4M+26.7% | $754.0M |
| Other | $37.0M+17.0% | $31.6M+39.4% | $22.7M+770.0% | $2.6M+279.2% | $688K-82.0% | $3.8M+28.1% | $3.0M |
| Total revenues | $3.95B+46.1% | $2.70B+48.3% | $1.82B+27.2% | $1.43B+22.8% | $1.17B+21.7% | $959.2M+26.7% | $757.0M |
| Medical expenses | $3.46B+43.8% | $2.41B+48.3% | $1.62B+29.8% | $1.25B+20.3% | $1.04B+31.0% | $793.0M+19.9% | $661.4M |
| Selling, general, and administrative expenses | $443.4M+19.4% | $371.4M+20.8% | $307.4M+4.0% | $295.6M+1.6% | $291.0M+86.1% | $156.4M+42.0% | $110.1M |
| Depreciation and amortization | $30.4M+13.1% | $26.9M+25.5% | $21.4M+24.0% | $17.3M+9.2% | $15.8M+4.8% | $15.1M+1.2% | $14.9M |
| Total expenses | $3.93B+40.2% | $2.81B+43.7% | $1.95B+24.9% | $1.56B+16.1% | $1.35B+39.5% | $964.5M+22.6% | $786.4M |
| Income (loss) from operations | $14.8M+114.5% | -$101.6M+20.5% | -$127.8M+0.6% | -$128.6M+27.8% | -$178.1M-3283.5% | -$5.3M+82.1% | -$29.5M |
| Interest expense | $15.8M-32.9% | $23.5M+10.9% | $21.2M+16.1% | $18.3M+4.9% | $17.4M+3.0% | $16.9M+13.7% | $14.9M |
| Other income, net | -$89K-23.6% | -$72K+91.6% | -$853K-584.7% | $176K-99.0% | $17.2M-2.5% | $17.7M+15.8% | $15.2M |
| Loss on extinguishment of debt | $0-100.0% | $3.0M | $0-100.0% | $2.2M | $0 | $0 | — |
| Total other expenses | $15.7M-40.7% | $26.5M+30.0% | $20.4M-1.4% | $20.7M+20.0% | $17.2M-2.5% | $17.7M+15.8% | $15.2M |
| Loss before income taxes | -$958K+99.3% | -$128.1M+13.6% | -$148.2M+0.7% | -$149.3M+23.5% | -$195.3M-751.8% | -$22.9M+48.7% | -$44.7M |
| Total | $20K-4.8% | $21K+195.5% | -$22K-106.5% | $339K | $0 | $0 | $0 |
| Net loss | -$978K+99.2% | -$128.1M+13.6% | -$148.2M+1.0% | -$149.6M+23.4% | -$195.3M-751.8% | -$22.9M | — |
| Less: Net loss attributable to noncontrolling interest | -$254K-605.6% | -$36K+76.9% | -$156K-269.6% | $92K | $0 | $0 | — |
| Net loss attributable to Alignment Healthcare, Inc. | -$724K+99.4% | -$128.0M+13.5% | -$148.0M+1.0% | -$149.5M+23.4% | -$195.3M-751.8% | -$22.9M+48.7% | -$44.7M |
| Total weighted-average common shares outstanding - basic (in shares) | 198.01B+3.8% | 190.79B+2.5% | 186.21B+2.8% | 181.21B | — | — | — |
| Total weighted-average common shares outstanding - diluted (in shares) | 198.01B+3.8% | 190.79B+2.5% | 186.21B+2.8% | 181.21B | — | — | — |
| Net loss per share attributable to Alignment Healthcare, Inc. - basic (in dollars per share) | $0.00+100.0% | -$670.00+15.2% | -$790.00+4.8% | -$830.00+27.2% | -$1140.00-660.0% | -$150.00 | — |
| Net loss per share attributable to Alignment Healthcare, Inc. - diluted (in dollars per share) | $0.00+100.0% | -$670.00+15.2% | -$790.00+4.8% | -$830.00+27.2% | -$1140.00-660.0% | -$150.00 | — |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.